Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...

From October 28th to 30th, Kexing Biopharm participated in CPHI Frankfurt 2025, one of the world's most influential pharmaceutical exhibitions, presenting its key product portfolio and international ...

Global cosmetics ODM (research, development, and production) company Cosmax recently succeeded in diversifying the synthesis ...

RESEARCHERS at Massachusetts Institute of Technology (MIT) have developed a method to purify gene therapies 10 times more quickly than conventional processes, paving the way to lower prices for the ...

Chile is home to one of the world’s largest salmon-farming industries, making it a vital hub for aquaculture vaccine demand. Salmon alone accounts for about 85 % of the vaccines used in Chile’s ...

The global market for anti-infective vaccines is entering a period of robust growth, driven by mounting infectious-disease burden, rising immunisation awareness and accelerating vaccine platform ...

Flanders Institute for Biotechnology (VIB), biologist Jessie Vandierendonck has been investigating new, alternative ...

An RNAi based genetic screen and subsequent analyses reveal how dyneins and small GTPases coordinate autophagosome positioning at the ncMTOC in fat cells, advancing understanding of autophagic vesicle ...

Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will showcase 46 abstracts, including 12 oral presentations, from its industry-leading hematology portfolio ...